Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,805 | 4 | 47.4% |
| Consulting Fee | $5,631 | 2 | 34.2% |
| Food and Beverage | $1,997 | 64 | 12.1% |
| Travel and Lodging | $995.09 | 5 | 6.0% |
| Education | $26.73 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $15,349 | 17 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $222.65 | 19 | $0 (2018) |
| Merck Sharp & Dohme LLC | $178.20 | 5 | $0 (2023) |
| AbbVie Inc. | $154.92 | 3 | $0 (2021) |
| PFIZER INC. | $128.19 | 11 | $0 (2017) |
| Lundbeck LLC | $93.03 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.92 | 4 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $54.68 | 3 | $0 (2017) |
| Amgen Inc. | $53.79 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $31.44 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $8,430 | 11 | Astellas Pharma US Inc ($8,261) |
| 2022 | $4,564 | 5 | Astellas Pharma US Inc ($4,564) |
| 2021 | $124.99 | 1 | AbbVie Inc. ($124.99) |
| 2020 | $2,506 | 3 | Astellas Pharma US Inc ($2,506) |
| 2018 | $47.67 | 3 | Sunovion Pharmaceuticals Inc. ($29.10) |
| 2017 | $780.32 | 53 | Janssen Pharmaceuticals, Inc ($204.08) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | Eisai Inc. | Leqembi (Drug) | Education | Cash or cash equivalent | $26.73 | General |
| Category: Neurology | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,735.00 | General |
| Category: Biological | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 08/30/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Biological | ||||||
| 08/30/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $117.74 | General |
| Category: Biological | ||||||
| 08/30/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $110.04 | General |
| Category: Biological | ||||||
| 07/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $520.00 | General |
| Category: Biological | ||||||
| 06/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,470.00 | General |
| Category: Biological | ||||||
| 06/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $103.53 | General |
| Category: Biological | ||||||
| 01/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/24/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2022 | Astellas Pharma US Inc | — | Consulting Fee | Cash or cash equivalent | $3,396.00 | General |
| 11/18/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $299.75 | General |
| 11/17/2022 | Astellas Pharma US Inc | — | Travel and Lodging | Cash or cash equivalent | $607.20 | General |
| 11/17/2022 | Astellas Pharma US Inc | — | Travel and Lodging | Cash or cash equivalent | $138.32 | General |
| 11/17/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $123.22 | General |
| 07/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Astellas Pharma US Inc | — | Consulting Fee | Cash or cash equivalent | $2,235.00 | General |
| 03/06/2020 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $235.46 | General |
| 03/06/2020 | Astellas Pharma US Inc | — | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| 12/19/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Respiratory | ||||||
| 11/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 12/07/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Endocrinology | ||||||
| 12/05/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 540 | 887 | $166,956 | $61,938 |
| 2022 | 9 | 544 | 923 | $177,041 | $64,572 |
| 2021 | 10 | 589 | 951 | $203,741 | $73,471 |
| 2020 | 9 | 590 | 939 | $201,440 | $61,063 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 212 | 297 | $48,606 | $20,625 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 145 | 283 | $30,778 | $13,840 | 45.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 135 | $36,585 | $12,457 | 34.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 61 | $32,147 | $8,626 | 26.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 45 | 58 | $16,356 | $5,358 | 32.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 16 | 17 | $1,836 | $836.02 | 45.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 33 | 36 | $648.00 | $195.17 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 246 | 400 | $68,088 | $28,081 | 41.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 148 | $40,108 | $12,531 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 128 | 215 | $25,179 | $10,648 | 42.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 38 | $20,026 | $5,868 | 29.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 24 | 32 | $9,024 | $2,804 | 31.1% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 17 | $8,228 | $2,523 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 27 | 28 | $3,117 | $1,107 | 35.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 14 | $2,674 | $817.93 | 30.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 30 | 31 | $598.00 | $192.78 | 32.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 241 | 386 | $74,974 | $30,436 | 40.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 43 | 156 | $42,276 | $13,472 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 128 | 206 | $28,629 | $10,654 | 37.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 45 | $23,715 | $7,392 | 31.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 37 | 47 | $13,254 | $4,118 | 31.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 17 | 18 | $8,712 | $2,735 | 31.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 21 | 21 | $6,845 | $2,271 | 33.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 27 | 34 | $2,278 | $1,450 | 63.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 13 | $2,483 | $787.28 | 31.7% |
About Dr. David Ko, MD
Dr. David Ko, MD is a Internal Medicine healthcare provider based in Rancho Mirage, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568405470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ko, MD has received a total of $16,454 in payments from pharmaceutical and medical device companies, with $8,430 received in 2023. These payments were reported across 76 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,805).
As a Medicare-enrolled provider, Ko has provided services to 2,263 Medicare beneficiaries, totaling 3,700 services with total Medicare billing of $261,043. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rancho Mirage, CA
- Active Since 06/14/2006
- Last Updated 12/27/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568405470
Products in Payments
- Veozah (Drug) $8,261
- XARELTO (Drug) $201.14
- UBRELVY (Drug) $124.99
- VERQUVO (Drug) $124.88
- ONFI (Drug) $93.03
- STIOLTO (Drug) $69.92
- VIAGRA (Drug) $67.29
- Prolia (Biological) $53.79
- ENTRESTO (Drug) $36.77
- ANORO (Drug) $31.44
- Androgel (Drug) $29.93
- LONHALA MAGNAIR (Drug) $29.10
- VIVLODEX (Drug) $27.27
- ELIQUIS (Drug) $26.98
- Leqembi (Drug) $26.73
- LYRICA (Drug) $24.57
- ASMANEX (Drug) $23.64
- INVOKANA (Drug) $21.51
- COSENTYX (Biological) $17.91
- XIFAXAN (Drug) $17.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rancho Mirage
Rodolfo Batarse, M.d, M.D
Internal Medicine — Payments: $1.1M
Dr. Evangelos Diamantakos, D.o, D.O
Internal Medicine — Payments: $125,909
Suzanne Chaves, Md, MD
Internal Medicine — Payments: $25,547
Meng Zhao, Md, MD
Internal Medicine — Payments: $10,067
Dr. Tyler Davis, M.d, M.D
Internal Medicine — Payments: $9,078
Dr. Arun Chakrabarty, M.d, M.D
Internal Medicine — Payments: $6,995